Eliza Congdon
Overview
Explore the profile of Eliza Congdon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
2181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dean A, Pochon J, Bilder R, Sabb F, Congdon E, Ghahremani D, et al.
Assessment
. 2024 Nov;
:10731911241283410.
PMID: 39523501
Experimental cognitive tests are designed to measure particular cognitive domains, although evidence supporting test validity is often limited. The Consortium for Neuropsychiatric Phenomics test battery administered 23 experimental and traditional...
2.
Kwon M, Congdon E, Ping R, Levine S
J Intell
. 2024 Jul;
12(7).
PMID: 39057182
Children have persistent difficulty with foundational measurement concepts, which may be linked to the instruction they receive. Here, we focus on testing various ways to support their understanding that rulers...
3.
Balliu B, Douglas C, Seok D, Shenhav L, Wu Y, Chatzopoulou D, et al.
NPJ Digit Med
. 2024 Feb;
7(1):49.
PMID: 38418551
Over the last ten years, there has been considerable progress in using digital behavioral phenotypes, captured passively and continuously from smartphones and wearable devices, to infer depressive mood. However, most...
4.
Wolitzky-Taylor K, LeBeau R, Arnaudova I, Barnes-Horowitz N, Gong-Guy E, Fears S, et al.
JMIR Ment Health
. 2023 Jul;
10:e46200.
PMID: 37486735
Background: The global burden of anxiety and depression has created an urgent need for scalable approaches to increase access to evidence-based mental health care. The Screening and Treatment for Anxiety...
5.
Wade B, Loureiro J, Sahib A, Kubicki A, Joshi S, Hellemann G, et al.
Psychol Med
. 2022 Jun;
52(12):2399.
PMID: 35726509
No abstract available.
6.
Wade B, Loureiro J, Sahib A, Kubicki A, Joshi S, Hellemann G, et al.
Psychol Med
. 2022 May;
52(12):2376-2386.
PMID: 35578581
Background: Ketamine is a rapidly-acting antidepressant treatment with robust response rates. Previous studies have reported that serial ketamine therapy modulates resting state functional connectivity in several large-scale networks, though it...
7.
Ketamine's modulation of cerebro-cerebellar circuitry during response inhibition in major depression
Loureiro J, Sahib A, Vasavada M, Leaver A, Kubicki A, Wade B, et al.
Neuroimage Clin
. 2021 Sep;
32:102792.
PMID: 34571429
Patients with major depressive disorder (MDD) exhibit impaired control of cognitive and emotional systems, including deficient response selection and inhibition. Though these deficits are typically attributed to abnormal communication between...
8.
Kodish T, Lau A, Gong-Guy E, Congdon E, Arnaudova I, Schmidt M, et al.
Adm Policy Ment Health
. 2021 Sep;
49(2):267-282.
PMID: 34505211
Although college campuses are diversifying rapidly, students of color remain an underserved and understudied group. Online screening and subsequent allocation to treatment represents a pathway to enhancing equity in college...
9.
Kruse J, Olmstead R, Hellemann G, Breen E, Tye S, Brooks 3rd J, et al.
J Psychiatr Res
. 2021 Jun;
140():350-356.
PMID: 34139457
Introduction: In cross-sectional studies of depressed patients, relationships between depression and levels of IL-8 are inconsistent, and have not been examined in relation to sex. Given identified sex differences in...
10.
Lam M, Chen C, Ge T, Xia Y, Hill D, Trampush J, et al.
Neuropsychopharmacology
. 2021 May;
46(10):1788-1801.
PMID: 34035472
Broad-based cognitive deficits are an enduring and disabling symptom for many patients with severe mental illness, and these impairments are inadequately addressed by current medications. While novel drug targets for...